Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126600) titled 'A Multicenter Study of ML-PopPK/PD Strategy for Personalized Tacrolimus in Early Postoperative Infant Liver Transplantation' on June 11.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

Condition: Rejection after pediatric liver transplantation

Intervention: Conventional Dosing Group:PopPK-ML Integrated Model-Guided Dosing

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-12

Target Sample Size: Conventional Dosing Group:100;Model-Guided Dosing Group:100;

Countries of R...